<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/81A44B31-9FA4-4F0D-8EE5-09266DDE0A58"><gtr:id>81A44B31-9FA4-4F0D-8EE5-09266DDE0A58</gtr:id><gtr:name>Colorado State University</gtr:name><gtr:address><gtr:line1>Fort Collins</gtr:line1><gtr:line4>Fort Collins</gtr:line4><gtr:line5>CO 80523</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/81A44B31-9FA4-4F0D-8EE5-09266DDE0A58"><gtr:id>81A44B31-9FA4-4F0D-8EE5-09266DDE0A58</gtr:id><gtr:name>Colorado State University</gtr:name><gtr:address><gtr:line1>Fort Collins</gtr:line1><gtr:line4>Fort Collins</gtr:line4><gtr:line5>CO 80523</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8087A3C3-09A8-4495-8205-03AF95BFFB0E"><gtr:id>8087A3C3-09A8-4495-8205-03AF95BFFB0E</gtr:id><gtr:firstName>Jean</gtr:firstName><gtr:surname>Manson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FD%2F05241338"><gtr:id>D04227DD-FC96-40C7-8011-97B59276404A</gtr:id><gtr:title>Protein misfolding in neurodegenerative disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/D/05241338</gtr:grantReference><gtr:abstractText>We aim to investigate the mechanisms of protein misfolding that lead to neurodegenerative disorders, including defining how, why and when it may occur in vivo. The study of well defined model systems such as the TSEs are expected to identify mechanisms which will be common to other protein misfolding diseases. The objectives of this theme are: To define the detailed molecular mechanisms underpinning protein misfolding. To define the roles of amino acid changes in protein misfolding. To define the contribution of post-translational modifications to the misfolding process. To define the roles of misfolded isoforms of protein in the pathobiology of disease.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-08-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>1057714</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Rocky Mountain Laboratories</gtr:department><gtr:description>QuIC analysis of low PrPSc mouse models</gtr:description><gtr:id>1C2C22F9-292A-4070-B7E5-342BCE7B5406</gtr:id><gtr:impact>Vascellari S, Orr&amp;ugrave; CD, Hughson AG, King D, Barron RM, Wilham JM, Baron GS, Race B, Pani A and Caughey B (2012). Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. PLoS One 7:e48969</gtr:impact><gtr:outcomeId>58c0398a785ed6.49072650-1</gtr:outcomeId><gtr:partnerContribution>Performed QuIC analysis of material from our mouse model</gtr:partnerContribution><gtr:piContribution>Provision of brain tissue from an unique mouse model of TSE disease</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Colorado State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Seeding protein aggregation in mice</gtr:description><gtr:id>6FEDD0D0-D5C0-4D43-8C22-2401DE6B7F64</gtr:id><gtr:impact>Piccardo P, King D, Telling G, Manson JC and Barron RM (2013). Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy. J Virol. 87:12349-12356 doi: 10.1128/JVI.00673-13</gtr:impact><gtr:outcomeId>58c038d8a4e224.10780919-1</gtr:outcomeId><gtr:partnerContribution>Provision of mice and tissue from animals overexpressing 101L PrP</gtr:partnerContribution><gtr:piContribution>Analysis of amyloid plaque seeding in mouse brain</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Roslin Institute Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>45713EDC-147C-49DB-BDF8-039E2E639B4C</gtr:id><gtr:impact>Each year we run an activity designed to engage the public and introduce them to the work we do on TSE diseases, protein misfolding and neurodegeneration</gtr:impact><gtr:outcomeId>58a5ace7671530.18243723</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Prion 2016 chair and invited speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7D5BFCBB-762D-43DA-9A4B-605F5C8F6619</gtr:id><gtr:impact>invited talk to international meeting</gtr:impact><gtr:outcomeId>58bd4b2822fce3.86560366</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BNA Streetfair</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3D633410-0023-4B77-9CFD-63E72A757070</gtr:id><gtr:impact>British Neuroscience Association Streetfair, held at the Barbican Centre in London alongside the annual BNA symposium. Activity to communicate work we do on TSE disease, protein misfolding and neurodegeneration to the public</gtr:impact><gtr:outcomeId>58a5b1690ad405.02402433</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have identified post-translational modifications which can impact on prion protein misfolding. The amino acid at codon 141 of ovine PrP was shown to be a key determinant of susceptibility to acquired prion disease.
The analysis of natural occurring ovine PrP protein variants for biochemical characteristics showed how they may modulate prion replication Our studies have shown that the level of proteolytic processing of ovine PrPC is associated with PRNP genotype and that fibrillisation of full-length PrPC can be inhibited by smaller PrPC fragments.
Transgenic mice overexpressing mutant 101L PrP were shown to form PrP amyloid plaques in the brain during aging, but did not develop clinical signs of TSE. Thus we have demonstrated PrP amyloid plaques can be seeded in the absence of agent replication, and misfolded/aggregated PrP is therefore not necessarily infectious or neurotoxic.</gtr:description><gtr:exploitationPathways>through further research</gtr:exploitationPathways><gtr:id>9D33667E-A2A4-4360-9227-9CE86B0F9335</gtr:id><gtr:outcomeId>56d06672b82f83.62790658</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the UK SEAC Advisory Body</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>09964177-7503-4303-B5C3-EA66CEE5BB68</gtr:id><gtr:impact>Spongiform Encephalopathy Advisory Committee advised Government on all accept of the Transmissible Spongiform Encephalopathies throughout the BSE and vCJD epidemics</gtr:impact><gtr:outcomeId>RriG7TJeFFs</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the CJD Sample Oversight Committee Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EB87D549-90B3-4EF8-816A-D02B87F72168</gtr:id><gtr:impact>The committee aims to facilitate the development of diagnostics for vCJD through working with developers and providing access to rare samples</gtr:impact><gtr:outcomeId>rkpScXXqDHh</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the International Science Advisory Council of APRI</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>35E9730E-E519-4A54-BB02-CB61DFC70FE2</gtr:id><gtr:impact>The importance of this committee which I now chair is to provide scientific knowledge and expertise to the growing scientific community of the APRI</gtr:impact><gtr:outcomeId>ZWNVcPTjyBh</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the British Neuroscience Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>10111367-E55C-47FF-87FB-169D550A8AED</gtr:id><gtr:outcomeId>pz9cTFBTzRy</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the ACDP</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8A36C863-0D48-41C8-92B6-D55C895DED7B</gtr:id><gtr:impact>The Advisory Committee on Dangerous pathogens advises the UK government on all issues related to dangerous pathogens from situations, in the field, in health care and laboratory practice. I serve on the committee as the expert on the Transmissible Spongiform Encephalopathies</gtr:impact><gtr:outcomeId>bvz7Yv6fNjU</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO TSE Working Group</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>006E3897-1622-4A4C-B25A-ED40FBEE2381</gtr:id><gtr:impact>developed policy on prion diseases</gtr:impact><gtr:outcomeId>qwPK2twTjcL</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the European Food Safety Authority</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A9C42D76-8F65-4FF8-B73A-3C7F124B6DB9</gtr:id><gtr:impact>involved in development of policy on prion diseases</gtr:impact><gtr:outcomeId>tLEj8xgWTLE</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5CDDFA52-03A0-460A-82F3-D5D16729FD8F</gtr:id><gtr:title>Effect of enzymatic deimination on the conformation of recombinant prion protein.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a9c42f4ebf75daf2f9518ca23da84a5"><gtr:id>6a9c42f4ebf75daf2f9518ca23da84a5</gtr:id><gtr:otherNames>Young DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56d8207248d577.61961763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43B9B155-ABD1-416E-900E-8F438B2148B9</gtr:id><gtr:title>Deciphering the molecular details for the binding of the prion protein to main ganglioside GM1 of neuronal membranes.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbc3c52d46dacd574a24f3d7efb0f4eb"><gtr:id>bbc3c52d46dacd574a24f3d7efb0f4eb</gtr:id><gtr:otherNames>Sanghera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>56d82072b23d38.27663453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07EFB1F7-EEC5-4D63-B876-E9D4B3B10F18</gtr:id><gtr:title>Membrane pathology and microglial activation of mice expressing membrane anchored or membrane released forms of A&amp;Icirc;&amp;sup2; and mutated human Alzheimer's precursor protein (APP).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4dc600f7d8b2e3a9ea1c7b4a990a8c3"><gtr:id>a4dc600f7d8b2e3a9ea1c7b4a990a8c3</gtr:id><gtr:otherNames>Jeffrey M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56d820744bdff5.94122143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>927F417A-9217-4673-8855-8056137372F7</gtr:id><gtr:title>Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4dc600f7d8b2e3a9ea1c7b4a990a8c3"><gtr:id>a4dc600f7d8b2e3a9ea1c7b4a990a8c3</gtr:id><gtr:otherNames>Jeffrey M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>58a58ff18eff97.97370451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89187D64-0C22-465D-AC2D-38DD7814B179</gtr:id><gtr:title>Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94335e3ffdd68f570e68800208c21e2a"><gtr:id>94335e3ffdd68f570e68800208c21e2a</gtr:id><gtr:otherNames>Vascellari S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58a58ff1b08858.73264940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19296A34-C90F-4616-96FF-F9526D520AFC</gtr:id><gtr:title>Significant differences in incubation times in sheep infected with bovine spongiform encephalopathy result from variation at codon 141 in the PRNP gene.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9365e2085bcda6ddbebe3f158c40550"><gtr:id>c9365e2085bcda6ddbebe3f158c40550</gtr:id><gtr:otherNames>Tan BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56c1fc7606b2a7.41090992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA63C7A9-F24E-4584-807A-521C8D897433</gtr:id><gtr:title>Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/019bc162157a51d23c7f4d0c63546b24"><gtr:id>019bc162157a51d23c7f4d0c63546b24</gtr:id><gtr:otherNames>Gill AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>56d82072e65a52.18538465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B54746C7-F0C1-444E-8E13-D2482F253496</gtr:id><gtr:title>Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53c8efb06cb6f533b3a1455c614bbb1d"><gtr:id>53c8efb06cb6f533b3a1455c614bbb1d</gtr:id><gtr:otherNames>Piccardo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56c1fc7535d027.85781073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB18535F-76AD-41C8-A3CA-898DE6A943B4</gtr:id><gtr:title>Molecular model of prion transmission to humans.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>58a58ff28fed87.76483780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BD93B18-FEC3-4514-942D-BABC9BB77B3E</gtr:id><gtr:title>The PrP(C) C1 fragment derived from the ovine A136R154R171PRNP allele is highly abundant in sheep brain and inhibits fibrillisation of full-length PrP(C) protein in vitro.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a05ec1d8835443963f4ad46c53fe17bd"><gtr:id>a05ec1d8835443963f4ad46c53fe17bd</gtr:id><gtr:otherNames>Campbell L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56d8206ede9d20.18668805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AF2C6CA-628F-4EC3-BF4A-55D093E1147A</gtr:id><gtr:title>Low density subcellular fractions enhance disease-specific prion protein misfolding.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f50b3c8ae7e7929d67b3b1fc0bb2961"><gtr:id>8f50b3c8ae7e7929d67b3b1fc0bb2961</gtr:id><gtr:otherNames>Graham JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56d820736478b0.37119594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF8FFAE3-B3E7-4FA8-BF34-A25EB2D96EFC</gtr:id><gtr:title>Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ad7a7e7fb27a43102aaf6f8e6da67b"><gtr:id>c0ad7a7e7fb27a43102aaf6f8e6da67b</gtr:id><gtr:otherNames>Kirby L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>56d8206eae0720.62289978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BC6F012-435A-42C1-BBEE-04933D940D86</gtr:id><gtr:title>Lysine hydroxylation and O-glycosylation in the globular, C-terminal region of mammalian-expressed, recombinant PrP</gtr:title><gtr:parentPublicationTitle>International Journal of Mass Spectrometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb8a027a44883e77ce48472f6dc56cf3"><gtr:id>bb8a027a44883e77ce48472f6dc56cf3</gtr:id><gtr:otherNames>Ritchie M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56d825f2480753.01235493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>600CF410-791C-4DA2-9C1C-DA8DEECE55BA</gtr:id><gtr:title>Na+/K+-ATPase is present in scrapie-associated fibrils, modulates PrP misfolding in vitro and links PrP function and dysfunction.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f50b3c8ae7e7929d67b3b1fc0bb2961"><gtr:id>8f50b3c8ae7e7929d67b3b1fc0bb2961</gtr:id><gtr:otherNames>Graham JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d82072726778.74879642</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/D/05241338</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>